EP2062581A1 — The antibiotics composition comprising beta-lactam antibiotics and ionic chelating agents
Assigned to Tianjin Hemay Biotechnology Co Ltd · Expires 2009-05-27 · 17y expired
What this patent protects
The antibiotics composition comprising at least one of beta-lactam antibiotics and at least one of ionic chelating agents used for inhibiting particulate formation, further comprising at least one of beta-lactamase inhibitors or buffers, or at least one of beta-lactamase inhibito…
USPTO Abstract
The antibiotics composition comprising at least one of beta-lactam antibiotics and at least one of ionic chelating agents used for inhibiting particulate formation, further comprising at least one of beta-lactamase inhibitors or buffers, or at least one of beta-lactamase inhibitors and buffers simultaneously. The composition can be formulated with at least one of aminoglycoside antibiotics into solution for controlling microbial infection in a container.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.